Genscript Biotech Corporation Stock
Stocks
1548
KYG3825B1059
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.99 HKD | +4.97% |
|
+12.74% | +20.45% |
| Market Cap | 3.99B 31.25B 3.48B 3.22B 2.98B 5.6B 383B 5.71B 38.41B 15.07B 188B 14.98B 14.65B 646B | P/E 2026 * |
45.8x | P/E 2027 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3.95B 30.92B 3.45B 3.19B 2.94B 5.55B 379B 5.65B 38.01B 14.91B 186B 14.82B 14.49B 639B | EV / Sales 2026 * |
4.84x | EV / Sales 2027 * | 4.17x |
| Free-Float |
55.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Genscript Biotech Corporation
| 1 day | +4.76% | ||
| 1 week | +12.74% | ||
| Current month | +22.32% | ||
| 1 month | +26.78% | ||
| 3 months | +12.40% | ||
| 6 months | +4.76% | ||
| Current year | +20.45% |
| 1 week | 13 |  | 15.03 |
| 1 month | 10.62 | | 15.03 |
| Current year | 10.36 | | 15.68 |
| 1 year | 10.36 | | 19.4 |
| 3 years | 7.43 | | 24.95 |
| 5 years | 7.43 | | 43.4 |
| 10 years | 1.23 | | 43.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Weihui Shao
CEO | Chief Executive Officer | - | 2022-12-31 |
Ye Wang
PSD | President | 57 | 2017-11-30 |
Josie Zhou
DFI | Director of Finance/CFO | - | 2025-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
John Quelch
BRD | Director/Board Member | 74 | 2024-11-13 |
Li Zhu
BRD | Director/Board Member | 76 | - |
Fang Liang Zhang
CHM | Chairman | 61 | 2001-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jun. 07 | Other | Director | -3,029 | 0.0001% | ||
| Jun. 07 | Other | -313,650 | 0.0143% | |||
| Jun. 03 | Other | Chairman | 169,561 | 0.0077% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.11% | +12.74% | -2.48% | -9.33% | 4B | |
| -1.05% | +1.39% | +3.15% | +6.98% | 50.61B | |
| +0.55% | -2.88% | +382.07% | +593.81% | 39.11B | |
| +0.13% | -0.19% | +29.79% | -6.00% | 34.64B | |
| +0.86% | -0.78% | +21.58% | +56.15% | 33.79B | |
| -1.31% | -3.03% | +2.51% | +25.24% | 26.89B | |
| +0.13% | -0.52% | - | - | 16.47B | |
| +1.13% | -1.85% | +67.36% | +120.46% | 15.14B | |
| -0.72% | +0.12% | +14.69% | +16.95% | 13.85B | |
| +1.13% | -0.44% | +12.34% | -31.79% | 12.72B | |
| Average | +0.56% | -0.63% | +59.00% | +85.83% | 24.72B | |
| Weighted average by Cap. | +0.04% | -0.86% | +79.31% | +119.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 816M 6.39B 713M 659M 609M 1.15B 78.36B 1.17B 7.86B 3.08B 38.37B 3.06B 3B 132B | 931M 7.3B 814M 752M 695M 1.31B 89.44B 1.33B 8.97B 3.52B 43.79B 3.5B 3.42B 151B |
| Net income | 74.8M 586M 65.37M 60.43M 55.83M 105M 7.19B 107M 721M 283M 3.52B 281M 275M 12.11B | 219M 1.71B 191M 177M 163M 308M 21.02B 313M 2.11B 827M 10.29B 822M 804M 35.44B |
| Net Debt | -41.61M -326M -36.36M -33.62M -31.06M -58.49M -4B -59.54M -401M -157M -1.96B -156M -153M -6.74B | -102M -802M -89.42M -82.67M -76.37M -144M -9.83B -146M -986M -387M -4.81B -384M -376M -16.57B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | HK$14.99 | +4.97% | 15,034,936 |
| 26-07-14 | HK$14.28 | -0.28% | 24,011,872 |
| 26-07-13 | HK$14.32 | +3.47% | 24,064,206 |
| 26-07-10 | HK$13.84 | +4.85% | 13,460,793 |
| 26-07-09 | HK$13.20 | -0.53% | 11,915,659 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1548 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
